Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models

MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO and KEUN-WOOK LEE
Anticancer Research May 2026, 46 (5) 2429-2443; DOI: https://doi.org/10.21873/anticanres.18128
MINSUNG PARK
1Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHENG HYUN LEE
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KUI-JIN KIM
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUNG-HYUN HWANG
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JI HEA SUNG
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MILANG NAM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MINSU KANG
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WOOCHAN PARK
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JI-WON KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JIN WON KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SE HYUN KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEONGMIN SEO
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EUN HEE JUNG
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOUNG JIN SUH
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YU JUNG KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEE HYUN KIM
1Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HYE SEONG LIM
4Panolos Bioscience, Inc., Hwaseong, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HYUN GUL YANG
4Panolos Bioscience, Inc., Hwaseong, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EUN BYUL CHO
4Panolos Bioscience, Inc., Hwaseong, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEUN-WOOK LEE
1Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: imdoctor{at}snu.ac.kr
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 46 (5)
Anticancer Research
Vol. 46, Issue 5
May 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO, KEUN-WOOK LEE
Anticancer Research May 2026, 46 (5) 2429-2443; DOI: 10.21873/anticanres.18128

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO, KEUN-WOOK LEE
Anticancer Research May 2026, 46 (5) 2429-2443; DOI: 10.21873/anticanres.18128
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Targeting AURKB Attenuates Tumor Growth in MYC-driven Lung Adenocarcinoma
  • Novel NOTCH1-unmutated T-ALL Cell Line With Suppressed Growth by Gamma-secretase Inhibitors
  • Beneficial Effects of Combining an Immune Checkpoint Inhibitor With Proton Radiation, OXi4503, or Hyperthermia in a Murine Solid Tumor Model
Show more Experimental Studies

Keywords

  • gastric cancer
  • VEGF
  • PlGF
  • anti-angiogenic therapy
  • PB101
  • combination therapy
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire